Takatsuki, Japan

Kazuhide Hayakawa

USPTO Granted Patents = 3 



Average Co-Inventor Count = 8.5

ph-index = 3

Forward Citations = 52(Granted Patents)


Location History:

  • Yokohama, JP (1994)
  • Osaka, JP (2008)
  • Takatsuki, JP (2014)

Company Filing History:


Years Active: 1994-2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazuhide Hayakawa: Innovator in Antitumor Compounds

Introduction

Kazuhide Hayakawa is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target undesirable cell proliferation.

Latest Patents

Hayakawa holds three patents, with his latest invention focusing on a pyrimidine compound and its medical applications. This compound is designed to therapeutically or prophylactically treat undesirable cell proliferation, showcasing superior activity in suppressing such growth. It is particularly effective as an antitumor agent for the treatment and prevention of cancer and rheumatism. Furthermore, the compound can enhance its antitumor efficacy when used in combination with other agents, such as alkylating agents or metabolism antagonists.

Career Highlights

Kazuhide Hayakawa is associated with Japan Tobacco Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments that address critical health issues.

Collaborations

Hayakawa has collaborated with notable colleagues, including Hisashi Kawasaki and Hiroyuki Abe, contributing to the development of groundbreaking medical solutions.

Conclusion

Kazuhide Hayakawa's work in developing pyrimidine compounds represents a significant advancement in the fight against cancer and other diseases. His contributions to the pharmaceutical industry highlight the importance of innovation in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…